Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-23-045595
Filing Date
2023-02-23
Accepted
2023-02-23 06:55:54
Documents
5

Document Format Files

Seq Description Document Type Size
1 POS AM d468419dposam.htm POS AM 310088
2 EX-5.1 d468419dex51.htm EX-5.1 25352
3 EX-23.1 d468419dex231.htm EX-23.1 1864
4 GRAPHIC g468419g04a04.jpg GRAPHIC 49807
5 GRAPHIC g468419page042.jpg GRAPHIC 9214
  Complete submission text file 0001193125-23-045595.txt   419957
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-255792 | Film No.: 23655852
SIC: 2836 Biological Products, (No Diagnostic Substances)